AF
AXDX icon

Advisornet Financial’s Accelerate Diagnostics AXDX Stock Holding History

Advisornet Financial’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-10
Closed -$1K – 1669
2020
Q3 		$1K Hold
10
– – ﹤0.01% 1605
2020
Q2 		$2K Hold
10
– – ﹤0.01% 1570
2020
Q1 		$1K Hold
10
– – ﹤0.01% 1639
2019
Q4 		$2K Hold
10
– – ﹤0.01% 1660
2019
Q3 		$2K Buy
+10
New +$1.93K ﹤0.01% 1667

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.32B AUM 31.14% 1-Year Est. Return
GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

Advisornet Financial's AXDX Position: Q4 2020 in Review

Advisornet Financial sold out of Accelerate Diagnostics (AXDX) in Q4 2020, closing a stake of 10 shares — an estimated $1K sold.

Advisornet Financial first reported a position in AXDX in Q3 2019 and held it in 5 quarters. The position peaked at $2K in Q2 2020. 115 funds tracked by Wall St. Rank hold AXDX as of Q4 2020.

  • Advisornet Financial reported no remaining Accelerate Diagnostics position as of Q4 2020 after selling out during the quarter.
  • Advisornet Financial sold 10 Accelerate Diagnostics shares in Q4 2020, an estimated $1K.
  • Advisornet Financial first reported a position in Accelerate Diagnostics in Q3 2019 and held it in 5 quarters.
  • Advisornet Financial's Accelerate Diagnostics position peaked at $2K in Q2 2020.
  • 115 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q4 2020.

Based on Advisornet Financial's 13F filing for Q4 2020, filed 4 Feb 2021.